This HTML5 document contains 53 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n6http://dx.doi.org/10.2967/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q57607587
rdf:type
wikibase:Item
schema:description
scientific article published on 13 December 2010 наукова стаття, опублікована в грудні 2010 artículu científicu espublizáu n'avientu de 2010 im Dezember 2010 veröffentlichter wissenschaftlicher Artikel wetenschappelijk artikel article scientifique publié en 2010
p:P577
wds:Q57607587-FEBD3D47-FBDF-4F72-B31C-26F65A20D8A4
wdt:P577
2010-12-13T00:00:00Z
p:P407
wds:Q57607587-427312C2-F6F5-445D-A2C0-68C863DDFCCE
wdt:P407
wd:Q1860
rdfs:label
18F-FDG PET as a Tool to Predict the Clinical Outcome of Infliximab Treatment of Rheumatoid Arthritis: An Explorative Study 18F-FDG PET as a Tool to Predict the Clinical Outcome of Infliximab Treatment of Rheumatoid Arthritis: An Explorative Study
skos:prefLabel
18F-FDG PET as a Tool to Predict the Clinical Outcome of Infliximab Treatment of Rheumatoid Arthritis: An Explorative Study 18F-FDG PET as a Tool to Predict the Clinical Outcome of Infliximab Treatment of Rheumatoid Arthritis: An Explorative Study
schema:name
18F-FDG PET as a Tool to Predict the Clinical Outcome of Infliximab Treatment of Rheumatoid Arthritis: An Explorative Study 18F-FDG PET as a Tool to Predict the Clinical Outcome of Infliximab Treatment of Rheumatoid Arthritis: An Explorative Study
p:P50
wds:Q57607587-317EF288-0F84-4EC6-B840-074AD47FD2EE wds:Q57607587-365DF08B-5A92-4BF7-B601-CC9CF8005EA7 wds:Q57607587-3A512BAA-064C-485D-ADD7-77AA19BD9020 wds:Q57607587-1AB8EBDE-0C76-4A64-B22C-6D1C6F6D45C6 wds:Q57607587-2D85F0DD-1BB5-4AD1-B275-18B808098DD0 wds:Q57607587-B22CF9B8-B68B-4C4E-B27E-800EE3F03BAA wds:Q57607587-645DA01F-93AC-406B-8776-F2327E79C210 wds:Q57607587-F22F6227-5D79-43C6-9016-F9D9BACA46F3
wdt:P50
wd:Q92890691 wd:Q92249859 wd:Q52983347 wd:Q114449351 wd:Q117267604 wd:Q88434154 wd:Q39842551 wd:Q117267567
p:P1476
wds:Q57607587-844BD26F-E8D9-4E6D-8B41-4DA53A061331
wdt:P1476
18F-FDG PET as a tool to predict the clinical outcome of infliximab treatment of rheumatoid arthritis: an explorative study
p:P304
wds:Q57607587-8248ED7A-F150-4A62-955F-2622E225844B
wdt:P304
77-80
p:P31
wds:Q57607587-6AE96330-1424-40C0-9F35-9ADFA91AED2D
wdt:P31
wd:Q13442814
p:P921
wds:Q57607587-0CACDA8A-FA47-4D84-8322-D93D69D93425
wdt:P921
wd:Q187255
p:P698
wds:Q57607587-8BCB1C69-9066-440A-A24E-75EC556A709F
wdtn:P698
n11:21149486
wdt:P698
21149486
p:P1433
wds:Q57607587-061E0C4D-FB07-4A1A-BA76-0011EFD8BABA
wdt:P1433
wd:Q7743608
p:P433
wds:Q57607587-A881A81A-3233-4996-82E6-663A0132ED02
p:P478
wds:Q57607587-B495EDBE-D38A-46AB-A265-D5A4D77A3863
wdt:P433
1
wdt:P478
52
p:P356
wds:Q57607587-857AC430-78F0-4D19-B3E3-046EA7174AA9
wdtn:P356
n6:JNUMED.110.076711
wdt:P356
10.2967/JNUMED.110.076711